Roivant Sciences Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Roivant Sciences Ltd.'s yearly results (2023–2026), compared with companies in United Kingdom. Tap ? on any ratio for what it means.
What stands out
- Self-Funding Ratio: Over the last 3 years operating cash was negative while the company kept spending on investment (capex). Lower than almost all companies in United Kingdom.
- Profit Cash Ratio: Over the last 3 years, every $100 of reported profit came with $-61 of operating cash. Lower than almost all companies in United Kingdom.
- Debt Due Cover Ratio: Operating cash was negative last year, while some debt falls due within a year. Lower than almost all companies in United Kingdom.
Cash quality
Profit Cash Ratio
$-61Over the last 3 years, every $100 of reported profit came with $-61 of operating cash.
Lower than almost all companies in United Kingdom.
Self-Funding Ratio
-166.0×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than almost all companies in United Kingdom.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 84% of companies in United Kingdom.
Growth Efficiency Ratio
—Sales fell 74%
Sales fell 74% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-74% / +139%In 3 years sales changed by -74% while total assets changed by +139%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-67.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than almost all companies in United Kingdom.
Cash Cushion Ratio
+15%Cash, after subtracting all debt, equals 15% of its market value (net cash).
Higher than 96% of companies in United Kingdom.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
Roivant Sciences Ltd. made a loss over the last year. Roivant Sciences Ltd. owes $0.07 for every $1 it owns. Roivant Sciences Ltd. made a loss in each of the last two years.
Compared with companies in United Kingdom · latest annual results Mar 2026.
P/E ratio
LossRoivant Sciences Ltd. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
6.39The share price is 6.39 times Roivant Sciences Ltd.'s book value per share, higher than 81% of companies in United Kingdom.
Market cap
$27.1 BThe total market value of all of Roivant Sciences Ltd.'s shares at today's price (share price × number of shares), larger than 65% of companies in United Kingdom. PosiCap size class: Tito Cap.
Net worth (book value)
$4.2 BWhat Roivant Sciences Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$5.86Net worth divided by the number of shares. The share price of $37.45 is 6.4 times this, which is the P/B above.
Return on equity (ROE)
-8.5%Roivant Sciences Ltd. lost 8.5% of its shareholders' money over the last year, lower than 98% of companies in United Kingdom.
Owes vs Owns
0.07×Roivant Sciences Ltd. owes $0.07 for every $1 it owns (low), lower than 98% of companies in United Kingdom.
Dividend yield
NoneRoivant Sciences Ltd. does not currently pay a dividend.
Revenue growth
-72%Revenue fell 72% in the year to Mar 2026, and shrank 36% a year on average over 3 years.
Profit growth
LossRoivant Sciences Ltd. made a loss in each of the last two years.
Profit margin
-3629.2%Roivant Sciences Ltd. lost $3629 for every $100 of revenue.
Cash vs debt
Net cashRoivant Sciences Ltd. held $4.2 B more cash than debt (net cash) at Mar 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Roivant Sciences Ltd.: $27.1 B ÷ $4.2 B (30 Jun 2026) = 6.4.
What is Roivant Sciences Ltd.'s return on equity?
Roivant Sciences Ltd. lost 8.5% of its shareholders' money over the last year, lower than 98% of companies in United Kingdom.
How much does Roivant Sciences Ltd. owe compared with what it owns?
Roivant Sciences Ltd. owes $0.07 for every $1 it owns (low), lower than 98% of companies in United Kingdom.
Does Roivant Sciences Ltd. pay a dividend?
No. Roivant Sciences Ltd. does not currently pay a dividend.
Is Roivant Sciences Ltd.'s revenue growing?
Revenue fell 72% in the year to Mar 2026, and shrank 36% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.